Company Directory - Pharmaco
Amphista Therapeutics is a biopharmaceutical company creating first-in-class therapeutics that harness the body’s natural processes to selectively and efficiently degrade and remove disease-causing proteins. The company’s pipeline of novel targeted protein degradation (TPD) based medicines is focused on challenging diseases including cancer.
Amplia Therapeutics Limited is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer.
We look beyond the ordinary, unearthing scientific potential and delivering medicines that have the potential to change the lives of people with rare, debilitating conditions. Through our in-depth knowledge and bold approach, we combine the expertise and innovation needed to help patients and their caregivers to access new treatments quickly and responsibly.
Founded in 1974 by Dr. Barry Sherman, we’re a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. From our humble origins of only two employees, we’ve grown to employ more than 8,000 people worldwide in manufacturing, R&D and commercial operations.
Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases. Arcellx’s vision is to bring ARC-SparX platform cell therapies to millions of patients who can self-administer prescribed SparX proteins under the care of academic and community practices.
Aristo Pharma was founded in 2008 and established itself as one of the most important pharmaceutical companies within a very short time. The company is run by management as an owner-managed medium-sized enterprise. Our product range is focused on well-known original products alongside a wide selection of the most important substances in the generics market.
Backed by the global strength of Strides and working off a strong foundation, Arrow is committed to supporting the future of Australian Retail Pharmacy and the communities they serve through its rapidly expanding portfolio of products, strategic partnerships and specialised engagement platforms.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes.
Ascendia Pharmaceuticals specializes in the invention and development of specialty pharmaceutical products and novel formulation technologies. We provide formulation, analytical, and manufacturing services to pharmaceutical companies, working collaboratively to provide innovative solutions to challenging drug delivery problems and to create advanced medicines.
Astex is a leader in innovative drug discovery and development, committed to the fight against cancer and diseases of the central nervous system (CNS). We are a member of one of Japan’s leading pharmaceutical companies, the Otsuka group, and therefore benefit from the resources and commitment of a global pharmaceutical company.
